Old Web
English
Sign In
Acemap
>
authorDetail
>
Yifang Shui
Yifang Shui
Zhengzhou University
Cancer research
Hazard ratio
Medicine
Confidence interval
Oncology
5
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Prognostic and clinicopathological significance of systemic immune-inflammation index in pancreatic cancer: a meta-analysis of 2,365 patients.
2021
Yifang Shui
Mengquan Li
Jing Su
Ming-xun Chen
Xiaobin Gu
Wenzhi Guo
Show All
Source
Cite
Save
Citations (0)
Downregulation of RBP4 indicates a poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma.
2021
Bioscience Reports
Mingxing Li
Wang Zhihui
Lixu Zhu
Yifang Shui
Shuijun Zhang
Wenzhi Guo
Show All
Source
Cite
Save
Citations (0)
MicroRNA‐4429 restrains colorectal cancer cell invasion and migration via regulating SMAD3‐induced epithelial–mesenchymal transition
2021
Journal of Cellular Physiology
Hongwen Li
Weijie Liang
Hongyu Zhang
Yifang Shui
Zhe Zhang
Show All
Source
Cite
Save
Citations (2)
β-glucan from Aureobasidium pullulans augments the anti-tumor immune responses through activated tumor-associated dendritic cells.
2021
International Immunopharmacology
Yifang Shui
Xin Hu
Hiroshi Hirano
Kisato Kusano
Hirotake Tsukamoto
Mengquan Li
Kenichiro Hasumi
Wenzhi Guo
Xiao-Kang Li
Show All
Source
Cite
Save
Citations (0)
A pooled analysis of the prognostic value of PD-L1 in melanoma: evidence from 1062 patients.
2020
Cancer Cell International
Jing Yang
Meilian Dong
Yifang Shui
Yue Zhang
Zhigang Zhang
Yin Mi
Xiaoxiao Zuo
Li Jiang
Ke Liu
Zheyan Liu
Xiaobin Gu
YongGang Shi
Show All
Source
Cite
Save
Citations (10)
1